Intrathecal baclofen for severe spasticity: five years experience.
Intrathecal baclofen for severe spasticity: five years experience.
复制标题
鞘内注射巴氯芬治疗严重痉挛：五年经验。
DOI：
--
复制
发表时间：
1991
期刊：
影响因子：
--
通讯作者：
E. Tan
中科院分区：
文献类型：
--
作者：
Stewart;Silbert Pl;S. Buffery;D. Perlman;E. Tan
严重痉挛是脊髓或大脑半球功能障碍患者康复中的一个主要问题。口服巴氯芬通常有效。然而，在重度痉挛患者中，口服药物可能无法获得充分的控制。在过去的5年中，我们已经开发了一个计划，使用鞘内巴氯芬严重痉挛，并在此讨论患者的评估，药物管理的实际方面，治疗并发症和患者的好处。持续鞘内注射巴氯芬是一种安全有效的物理治疗的辅助治疗重度痉挛患者。
Severe spasticity is a major problem in the rehabilitation of patients with dysfunction of the spinal cord or cerebral hemispheres. Oral baclofen is often effective. However, in patients with severe spasticity adequate control may not be obtained from oral therapy with the drug. Over the past 5 years we have developed a program for the use of intrathecal baclofen for severe spasticity, and in relation to this discuss patient assessment, practical aspects of drug administration, complications of therapy and patient benefits. Continuous intrathecal baclofen is a safe and effective adjunct to physical therapy in the management of patients with severe spasticity.